# Clarithromycin Resistant Tailored Therapy

> **NCT01453036** · PHASE4 · COMPLETED · sponsor: **Jin Il Kim** · enrollment: 924 (actual)

## Conditions studied

- Peptic Ulcer
- Helicobacter Pylori Infection

## Interventions

- **PROCEDURE:** 23S rRNA point mutation test of Helicobacter pylori
- **PROCEDURE:** UBT test & Gastroenterology with biopsy c silver stain

## Key facts

- **NCT ID:** NCT01453036
- **Lead sponsor:** Jin Il Kim
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 924 (ACTUAL)
- **Last updated:** 2013-09-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01453036

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01453036, "Clarithromycin Resistant Tailored Therapy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01453036. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*